PaperPaper Novel Small Molecule XPO1/CRM1 Inhibitors Induce Nuclear Accumulation of TP53, Phosphorylated MAPK and Apoptosis in Human Melanoma Cells External Link Read MorePaper Selective inhibitors of nuclear export (SINE) as novel therapeutics for prostate cancer External Link Read MorePaper Biologic activity of the novel orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 against canine melanoma cell lines External Link Read MorePaper Verdinexor, a novel Selective Inhibitor of Nuclear Export (SINE), reduces Influenza A virus replication in vitro and in vivo. External Link Read MorePaper KPT-330 has antitumour activity against non-small cell lung cancer External Link Read MorePaper A structure-based virtual screening approach for discovery of covalently bound ligands External Link Read MorePaper Selinexor suppresses downstream effectors of B-cell activation, proliferation and migration in chronic lymphocytic leukemia cells. External Link Read MorePaper Induction of p53-mediated transcription and apoptosis by Exportin-1 (XPO1) inhibition in mantle cell lymphoma. External Link Read MorePaper Clinical Translation of Nuclear Export Inhibitors in Cancer External Link Read MorePaper Genomic and molecular characterization of esophageal squamous cell carcinoma External Link Read More Previous 1 … 3 4 5 6 7 Next